152 related articles for article (PubMed ID: 11856781)
1. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation.
Abdi R; Huong TTB; Sahagun-Ruiz A; Murphy PM; Brenner BM; Milford EL; McDermott DH
J Am Soc Nephrol; 2002 Mar; 13(3):754-758. PubMed ID: 11856781
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor 2-V64I and chemokine receptor 5-Delta32 polymorphisms and clinical risk factors of delayed graft function and acute rejection in kidney transplantation.
Azmandian J; Mandegary A; Saber A; Torshabi M; Etminan A; Ebadzadeh MR; Fazeli F; Soleymani S; Taghipour A; Karimi MA
Iran J Kidney Dis; 2012 Jan; 6(1):56-62. PubMed ID: 22218121
[TBL] [Abstract][Full Text] [Related]
4. Allograft renal rejection and chemokine polymorphism.
Gorgi Y; Sfar I; Jendoubi-Ayed S; Makhlouf M; Rhomdhane TB; Bardi R; Aouadi H; Abdallah TB; Abderrahim E; Ayed K
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):18-23. PubMed ID: 21196609
[TBL] [Abstract][Full Text] [Related]
5. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival.
Yigit B; Bozkurt N; Berber I; Titiz I; Isbir T
Cell Biochem Funct; 2007; 25(4):423-6. PubMed ID: 16598837
[TBL] [Abstract][Full Text] [Related]
7. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population.
Singh N; Sinha N; Kumar S; Pandey CM; Agrawal S
Mol Biol Rep; 2012 Mar; 39(3):2753-9. PubMed ID: 21744265
[TBL] [Abstract][Full Text] [Related]
10. The effect of chemokine receptor gene polymorphisms (CCR2V64I, CCR5-59029G>A and CCR5Δ32) on renal allograft survival in Pakistani transplant patients.
Firasat S; Raza A; Abid A; Aziz T; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Khaliq S
Gene; 2012 Dec; 511(2):314-9. PubMed ID: 23041556
[TBL] [Abstract][Full Text] [Related]
11. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection.
Simeoni E; Vassalli G; Seydoux C; Ramsay D; Noll G; von Segesser LK; Fleury S
Transplantation; 2005 Nov; 80(9):1309-15. PubMed ID: 16314800
[TBL] [Abstract][Full Text] [Related]
12. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.
Nadif R; Mintz M; Rivas-Fuentes S; Jedlicka A; Lavergne E; Rodero M; Kauffmann F; Combadière C; Kleeberger SR
Cytokine; 2006 Feb; 33(3):171-8. PubMed ID: 16524739
[TBL] [Abstract][Full Text] [Related]
14. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
Bagci B; Bagci G; Huzmeli C; Sezgin I; Ozdemir O
Int Urol Nephrol; 2016 Jul; 48(7):1163-70. PubMed ID: 27118566
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
16. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CCR5-Delta32, CCR2-64I, SDF1-3'A, CX3CR1-249I, and CX3CR1-280M in Chinese populations.
Qian Y; Sun H; Lin K; Shi L; Shi L; Chu J
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1391-7. PubMed ID: 19032065
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation.
Krichen H; Khazen D; Sfar I; Ben Abdallah T; Bardi R; Jendoubi-Ayed S; Makhlouf M; Abderrahim E; Aouadi H; Ayed K; Gorgi Y
Transplant Proc; 2011 Mar; 43(2):433-6. PubMed ID: 21440726
[TBL] [Abstract][Full Text] [Related]
19. The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation.
Schröppel B; Fischereder M; Ashkar R; Lin M; Krämer BK; Mardera B; Schiano T; Murphy B
Am J Transplant; 2002 Aug; 2(7):640-5. PubMed ID: 12201365
[TBL] [Abstract][Full Text] [Related]
20. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
